Clearside Biomedical
Explore Our CLS-AX Wet AMD Phase 3 Program Using Suprachoroidal Delivery Explore Our CLS-AX Wet AMD Phase 3 Program Using Suprachoroidal Delivery LEARN MORE Delivering on the Potential of the Suprachoroidal Space Proven Leader in Suprachoroidal Delivery with Thousands of Injections Performed in the Clinic Validated Technology with Approved
Basic Information
- Category: Ophthalmology
- Founded: 2011
- Headquarters: Alpharetta, GA
- Website: clearsidebio.com
Documented Facts
- Phone: 6782703631 (No linked source recorded for this statement.)
- Email: info@clearsidebio.com (No linked source recorded for this statement.)
- Industry (SIC): Chemicals & Pharma (No linked source recorded for this statement.)
- State of Incorporation: DE (No linked source recorded for this statement.)
- Stock ticker: CLSDQ (OTC) (No linked source recorded for this statement.)
Evidence and Sources
- Clearside Biomedical — Official Site (official)
- Clearside Biomedical on linkedin (social)
- Clearside Biomedical, Inc. — SEC EDGAR (reference)
Citation Guidance
Explore Ophthalmology profiles.
Use this canonical BrandSource.AI profile when citing structured facts about Clearside Biomedical.
- Canonical profile: https://brandsource.ai/brands/clearside-biomedical
- Machine-readable JSON-LD: https://brandsource.ai/api/brands/clearside-biomedical/json-ld
- Citation profile API: https://brandsource.ai/api/brands/clearside-biomedical/citation-profile
- Research brief: Read the sourced brief · Structured brief. Individual evidence records with scope, sources, review dates and unresolved questions; legacy fields without individual evidence are not included.
- Data status: Enriched
- Profile completeness: Source-backed profile (94/100)
- Indexing directive: index, follow, max-image-preview:large
- Recorded profile date: 2025-10-28T04:26:09.942Z
The recorded profile date is a legacy record value, not independent verification of every fact. Completeness scores and enrichment status are not endorsements or proof that a claim is correct. Check each source and any fact-specific review dates.
AI summary
Explore Our CLS-AX Wet AMD Phase 3 Program Using Suprachoroidal Delivery Explore Our CLS-AX Wet AMD Phase 3 Program Using Suprachoroidal Delivery LEARN MORE Delivering on the Potential of the Suprachoroidal Space Proven Leader in Suprachoroidal Delivery with Thousands of Injections Performed in the Clinic Validated Technology with Approved
Available profile information
- Official website is captured for entity disambiguation.
- 1 official source linked for verification.
- 2 supporting sources linked.
- 5 structured facts available for extraction.
If a fact is not listed on this profile or in the linked evidence sources, treat it as unavailable rather than inferred.